Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CRARY | PCAR |
|---|---|---|
| Price | $9.45 | $109.36 |
| Change today | ▼ 0.42% | ▼ 0.29% |
| Market cap | $57.57B | $57.56B |
| Return, 3 months | -4.9% | -11.9% |
| Return, year to date | -1.0% | +0.7% |
| Return, 1 year | +6.2% | +13.7% |
| P/E (TTM) | 8.2 | 23.0 |
| P/B | 0.7 | 2.8 |
| P/E percentile vs own 5y | – | 93rd |
| Dividend yield | 6.94% | 1.23% |
| Revenue growth (YoY, latest qtr) | – | +0.5% |
| Net profit growth (YoY) | – | +3.9% |
| Gross margin | – | 16.5% |
| Operating margin | – | 10.0% |
| Net margin | – | 9.0% |
| Return on equity | – | 12.8% |
| Analyst target vs. price | – | +34.1% |
| Analyst buy share | – | 50% |
| RSI (14) | 23 | 21 |
| 30-day volatility | 22.7% | 16.1% |
| Max drawdown, 1 year | -20.0% | -20.7% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.